CORINNOVA IS DEVELOPING TECHNOLOGIES TO RESTORE HEART FUNCTION FOR HEART ... Proactive Investors USA & Canada The company develops technologies aimed at recovery for patients with end stage heart failure. Their target market is 70000 bedridden American heart failure patients with irregular heartbeats that can lead to muscle cell death, fibrosis, ... |
